Allergan reports 3Q loss, revenue rises 11.4%

Earnings Reuters

FILE PHOTO - The Allergan logo is seen in this photo illustration in Singapore November 23, 2015. REUTERS/Thomas White/File Photo (Copyright Reuters 2017)

(Reuters) - Botox-maker Allergan Plc (AGN) said on Wednesday its quarterly net sales rose 11.4 percent on higher demand for its medical aesthetics products.

Continue Reading Below

Net loss attributable to shareholders was $4.03 billion, or $12.07 per share, in the third quarter ended Sept. 30, compared with $15.15 billion, or $38.58 per share, a year earlier.

More on this...

The company said it took an impairment charge of $3.2 billion related to its dry-eye drug Restasis, as well as $1.3 billion in impairment charge related to Teva securities.

Net revenue rose 11.4 percent to $4.03 billion.

(Reporting by Tamara Mathias in Bengaluru; Editing by Anil D'Silva)

What do you think?

Click the button below to comment on this article.